Global Pulmonary Artery Catheter Market Report and Forecast 2024-2032

Global Pulmonary Artery Catheter Market Outlook

The global pulmonary artery catheter market size was valued at USD 1,272.74 million in 2023, driven by the rising population, increasing number of smokers, rising prevalence of diseases caused due to sedentary lifestyles of the consumers, and growing ageing population. The market is anticipated to grow at a CAGR of 4.4% during the forecast period 2024-2032 to reach a value of USD 1,875.19 million by 2032.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

North America to be One of the Leading Regional Markets for the Pulmonary Artery Catheter Industry

Due to sedentary lifestyles and the increase in cardiac complications, the United States and Canada are the major markets for pulmonary artery catheter within North America. Countries like India, Australia, and New Zealand are also among the major markets of pulmonary artery catheter due to the prevalence of poor diet, failure to exercise, and sedentary lifestyles. Lifestyle disorders are prevalent in these countries, which is further boosting the market growth.  Europe and Latin America are also witnessing a rapid growth within the market due to changing lifestyles and increasing investments into the healthcare sectors.

Pulmonary Artery Catheter: Market Segmentation

The pulmonary artery takes blood to the lungs for purification from the heart's right ventricle. Catheterisation of the pulmonary artery is a process in which a catheter is inserted into the pulmonary artery. The flow-focused balloon pulmonary artery catheter was first addressed in 1970 and initially designed for the treatment of acute myocardial infarction. It has since then been widely used in various critical diseases and operations. Pulmonary artery catheterisation is a surgical operation that inserts a small catheter into the neck, arm, chest, or vein and transfers to the right side of the heart to assess the heart pressure.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The types of the product can be divided as follows:

• Four-Lumen Catheter
• Five-Lumen Catheter
• Six-Lumen Catheter
• Others

Pulmonary artery catheter finds wide applications in:

• ICU
• Non-ICU

The end uses of the product include the following:

• Hospitals
• Cardiac Clinics 
• Ambulatory Surgical Centres
• Others

The regional markets for pulmonary artery catheter can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Rising Ageing Population Bolstering the Market Growth of Pulmonary Artery Catheter

The rapid rise in the ageing population is among the crucial factors driving the growth of the industry. The demand for pulmonary artery catheters is motivated by the preoperative, perioperative, and postoperative use of the pulmonary artery catheter. The number of cases of cardiac complications has risen with the growing health problems due to the sedentary lifestyles and unhealthy dietary habits. This has led to the growth of the pulmonary artery catheter industry. In addition, the increased prevalence of smoking and alcohol consumption have also resulted in increased heart problems, thus, further catalysing the market growth.

Key Industry Players in the Global Pulmonary Artery Catheter Market

The report gives a detailed analysis of the following key players in the global pulmonary artery catheter market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

• Edward Lifesciences Corporation
• Argon Medical Devices Inc.
• ICU Medical Inc.
• Biosensors International Group
• Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

Key Highlights of the Report